GEMIN4是一种潜在的治疗点,用于基底类乳腺癌亚型的患者
Liang Wu1, Yue Zhang2, Chunlei Zheng3
1Department of Emergency Surgery, The Second Affiliated Hospital of Qiqihar Medical University, Heilongjiang Province, Qiqihar, People's Republic of China.
BMC women's health
|July 28, 2023
概括
GEMIN4被确定为基底类乳腺癌 (BLBC) 的潜在诊断标志物和治疗标,基底类乳腺癌是一种预后不佳的亚型. 这项研究突出了GEMIN4的特点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 基底类乳腺癌 (BLBC) 占乳腺癌的10-20%,由于有效治疗有限,其存活率最低.
- 确定早期诊断标记物和BLBC的新疗法战略至关重要.
研究的目的:
- 探索早期BLBC的潜在诊断标志物.
- 为BLBC患者确定最佳的治疗策略.
主要方法:
- 权重基因共同表达网络分析 (WGCNA) 来识别与BLBC相关的基因模块.
- 候选基因的功能丰富分析 (GO,KEGG).
- 生存分析 (OS,RFS) 和体外实验 (siRNA,CCK8,BrdU) 来评估GEMIN4的作用.
主要成果:
- "红色模块"与BLBC有很高的相关性,产生了913个候选基因,富含雌激素信号和癌症通路.
- GEMIN4被确定为一种高度表达的基因,与BLBC患者的整体存活率 (OS) 和无复发存活率 (RFS) 相关.
- 通过siRNA介导的GEMIN4中断抑制了细胞活力和增殖,这表明它在BLBC进展中的作用.
结论:
- GEMIN4是BLBC的潜在诊断标记物.
- 在BLBC治疗中,GEMIN4是一个有前途的治疗标.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


